Multicentric Castleman Disease (MCD) Overview
Learn About Multicentric Castleman Disease (MCD)
View Main Condition: Castleman Disease
- Multicentric Castleman Disease
- Idiopathic multicentric Castleman's disease
- MCD
- Multicentric giant lymph node hyperplasia
- Multicentric plasma cell variant of Castleman's disease
- PMCD
- Plasmablastic multicentric Castleman disease
Eric Oksenhendler practices in Paris, France. Oksenhendler and is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, Unicentric Castleman Disease (UCD), and Splenectomy.
Lionel Galicier practices in Creteil, France. Galicier and is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Castleman Disease, Multicentric Castleman Disease (MCD), Thrombocytopenia, Splenectomy, and Bone Marrow Aspiration.
Karan Kanhai practices in Hemel Hempstead, United Kingdom. Kanhai and is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her top areas of expertise are Castleman Disease, Multicentric Castleman Disease (MCD), Lymphofollicular Hyperplasia, Lymphoid Hyperplasia, and Prostatic Artery Embolization.
Background: Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS) and KSHV-multicentric Castleman disease (MCD) occur in people living with HIV. These diseases cause severe inflammation that can be fatal if not treated.
Background: Primary effusion lymphoma (PEL) is an aggressive form of cancer that affects cells in the immune system and lymph nodes. How PEL develops is not well understood, and this disease does not respond well to standard treatments for other types of lymphomas.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

The Castleman Disease Collaborative Network (CDCN) is a global initiative dedicated to accelerating research and treatment for Castleman disease and revolutionizing biomedical research.